ReviewFrontiers in oncology2021

Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications.

Charalampos Charalampous et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.